SGCB and cirrhosis of liver: Schwabl et al. (2018) [41] reported that stimulation of sGC by riociguat decreased portal pressure and also improved fibrosis as demonstrated by histology and measurement of α-smooth muscle actin expression in BDL-induced and CCl4-induced liver cirrhosis.